Deals this week: Selecta Biosciences, bluebird bio, TransGenic

Selecta Biosciences intends to raise $50m through private placement of shares of its common stock to be subscribed to by new and existing institutional investors and one of the company ’s board of directors.

Source: Drug Development Technology - June 29, 2017 Category: Pharmaceuticals Source Type: news